How The Gov't Anti-Drug PR Review Got Derailed

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

When the White House issued a solicitation last month for the public relations portion of its anti-drug media campaign, the information was posted in a way that enabled readers to see material they shouldn’t have, such as the contract’s cost: $6 million a year.

Then, for reasons unrelated to the review, a federal judge’s order to shut down the Internet site where the RFQ was posted forced the Office of National Drug Control Policy to withdraw it.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in